Clinical Trials

Thymic tumor

Displaying 3 studies

  • Thymus Tissue Collection Rochester, MN

    Thymus tissue is standardly removed during neonatal congenital cardiac surgery. The collection of this tissue poses no additional risk to subjects. TRAG’s standard operating procedures will be followed to prepare, store, and provide the discarded tissue to Dr. Tuggle. An internal database will be used to record consent, date of collection, and date of shipment. After collection of the thymus tissue, there will be no further contact with subjects or families.  There will be no results to report and no information will become part of the subject’s medical record.

  • A Study to Evaluate Thymoma Recurrence Rochester, MN

    The purpose of this study is to evaluate thymoma recurrence rates in patients who underwent thymectomy.

  • A Study Of Surgical Drain Fluid For Detection Of Molecular Residual Disease (MRD) In Esophageal Cancer And Thymic Epithelial Tumors Rochester, MN

    To investigate if DNA cancer-associated-variants (CAV) in post-operative blood, tumor tissue and surgical drain fluid can correlate molecular residual disease (MRD) with clinical, radiographic, or pathologic recurrence or progression at 12- and 24- months post-surgery in patients with esophageal cancer and thymic epithelial tumors

.

Mayo Clinic Footer